In my opinion , OPK is undervalued at around $ 9 / share . The revenue from the BRLI group is about $ 1 billion / year . If we take an average 3 X of Price / sale ratio for health care companies then the contribution from the BRLI group is about $ 3 Bilion/ 0.5 billion shares = $ 6 / share The revenues from Rayaldee and others in the pipelines will make OPK worth much more than $9/share. As a side note , there is a chance of only 20 % that the democrate party can take over the house in this election .
DG..... Good luck with your health.... and I agree.. OPK is just taking too long... I am near my peak in shares... but if they miss November... Well... I can see myself winding down... Frost doesn't seem too interested in keeping Investors informed... He most likely plans on selling during a buyout... so... current pricing doesn't affect him so much... Tired of the lack... of correspondence... and not meeting planned dates...